Egypt’s pharma sales jump 26.8% in 1H2017

Egypt’s pharma industry saw a collective 26.8% y-o-y growth in sales revenue in 1H2017 to EGP 23.1 bn, according to data from industry research firm Quintiles IMS picked up by Al Borsa. Novartis the industry chart with revenues of EGP 1.8 bn, followed by GlaxoSmithKline at EGP 1.4 bn. France’s Sanofi’s sales grew to EGP 1.2 bn in the first half of the year.